User profiles for Steven J Warach
 | Steven WarachDell Medical School, University of Texas at Austin Verified email at austin.utexas.edu Cited by 48558 |
Tenecteplase thrombolysis for acute ischemic stroke
Tenecteplase is a fibrinolytic drug with higher fibrin specificity and longer half-life than the
standard stroke thrombolytic, alteplase, permitting the convenience of single bolus …
standard stroke thrombolytic, alteplase, permitting the convenience of single bolus …
Diffusion and perfusion magnetic resonance imaging: applications to functional MRI
D Le Bihan, SJ Warach - 1995 - journals.lww.com
Diffusion and Perfusion Magnetic Resonance Imaging: Applicat... : Journal of Computer
Assisted Tomography Diffusion and Perfusion Magnetic Resonance Imaging: Applications to …
Assisted Tomography Diffusion and Perfusion Magnetic Resonance Imaging: Applications to …
Symptomatic intracranial hemorrhage with tenecteplase vs alteplase in patients with acute ischemic stroke: the comparative effectiveness of routine tenecteplase vs …
Importance Symptomatic intracranial hemorrhage (sICH) is a serious complication of stroke
thrombolytic therapy. Many stroke centers have adopted 0.25-mg/kg tenecteplase instead of …
thrombolytic therapy. Many stroke centers have adopted 0.25-mg/kg tenecteplase instead of …
Acute stroke imaging research roadmap III imaging selection and outcomes in acute stroke reperfusion clinical trials: consensus recommendations and further …
Background and Purpose— The Stroke Imaging Research (STIR) group, the Imaging Working
Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the …
Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the …
Acute stroke imaging research roadmap II
Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology
sponsored a series of working group meetings> 12 months, with the final meeting occurring …
sponsored a series of working group meetings> 12 months, with the final meeting occurring …
Prospective observational cohort study of tenecteplase versus alteplase in routine clinical practice
Background: A 10-hospital regional network transitioned to tenecteplase as the standard of
care stroke thrombolytic in September 2019 because of potential workflow advantages and …
care stroke thrombolytic in September 2019 because of potential workflow advantages and …
Stroke thrombolysis with tenecteplase to reduce emergency department spread of coronavirus disease 2019 and shortages of alteplase
SJ Warach, JL Saver - JAMA neurology, 2020 - jamanetwork.com
Measures to reduce emergency department staff exposure to the severe acute respiratory
syndrome coronavirus 2 have focused on screening and use of personal protective equipment…
syndrome coronavirus 2 have focused on screening and use of personal protective equipment…
[HTML][HTML] Sex differences in outcome after endovascular stroke therapy for acute ischemic stroke
Background and Purpose— We determined the effect of sex on outcome after endovascular
stroke thrombectomy in acute ischemic stroke, including lifelong disability outcomes. …
stroke thrombectomy in acute ischemic stroke, including lifelong disability outcomes. …
Small vessel disease and clinical outcomes after IV rt‐PA treatment
Introduction Cerebral small vessel disease ( SVD ) contributes to dementia and disability in
the elderly, and may negatively affect stroke outcomes. We aimed to evaluate to what extent …
the elderly, and may negatively affect stroke outcomes. We aimed to evaluate to what extent …
Blood–brain barrier leakage increases with small vessel disease in acute ischemic stroke
Objective: In patients with acute ischemic stroke, we aimed to investigate the relation
between preexisting small vessel disease (SVD) and the amount of blood–brain barrier (BBB) …
between preexisting small vessel disease (SVD) and the amount of blood–brain barrier (BBB) …
